SEPA board meeting regarding Slice (Emamectin benzoate): EIR review

FOI reference: FOI/18/02663
Date received: 20 December 2017
Date responded: 17 January 2018

Information requested

• emails, discussions, and any other correspondence (particularly pertaining to Willie Cowan and Alastair Mitchell) with SEPA, the SSPO, Merck, SARF and SAMS

• a SEPA board meeting draft report on the issue of Slice (Emamectin benzoate) between 10 August 2016 and 1 November 2016.

Response

I have concluded that a different decision should be substituted.

In conducting my review I have re-examined the original searches and completed a further extensive search of all the Scottish Government records.

As a result of my search, I have identified information which would fall within the scope of your request. I apologise that we did not identify this information when dealing with your original request. I have determined that we were not entitled to apply an exception under regulation 10(4)(a) of the EIRs.

I enclose a copy of all the information held within the scope of your request. However, a small amount of information has been redacted from the enclosed emails as an exemption under Regulation 11(2) of EIRs (personal information). This exemption applies because the information is personal data, names and contact details of individuals and disclosing it would contravene the data protection principles in Schedule 1 to the Data Protection Act 1998.

This exemption is not subject to the 'public interest test', so we are not required to consider if the public interest in disclosing the information outweighs the public interest in applying the exemption.

About FOI

The Scottish Government is committed to publishing all information released in response to Freedom of Information requests. View all FOI responses at http://www.gov.scot/foi-responses

FOI-18-02663 - related documents.pdf

File type

3 page PDF

File size

271.3 kB